 | Michael A Gerber |
Prominent publications by Michael A Gerber
BACKGROUND: Two doses of either trivalent live attenuated or inactivated influenza vaccines (LAIV and TIV, respectively) are approved for young children (≥ 24 months old for LAIV and ≥ 6 months old for TIV) and induce protective antibody responses. However, whether combinations of LAIV and TIV are safe and equally immunogenic is unknown. Furthermore, LAIV is more protective than TIV in children for unclear reasons.
METHODS: Children 6-35 months old were administered, 1 month apart, 2 ...
| Also Ranks for: Young Children | laiv tiv | live vaccines | humoral responses | viral child |
BACKGROUND: The purpose of this statement is to update the recommendations by the American Heart Association (AHA) for the prevention of infective endocarditis that were last published in 1997.
METHODS AND RESULTS: A writing group was appointed by the AHA for their expertise in prevention and treatment of infective endocarditis, with liaison members representing the American Dental Association, the Infectious Diseases Society of America, and the American Academy of Pediatrics. The ...
| Also Ranks for: Infective Endocarditis | prophylaxis prevention | dental procedures patients | bacterial humans | recommendations heart association |
BACKGROUND: Children 6 through 35 months of age are recommended to receive half the dose of influenza vaccine compared with older children and adults.
METHODS: This was a 6-site, randomized 2:1, double-blind study comparing full-dose (0.5 mL) trivalent inactivated influenza vaccine (TIV) with half-dose (0.25 mL) TIV in children 6 through 35 months of age. Children previously immunized with influenza vaccine (primed cohort) received 1 dose, and those with no previous influenza ...
| Also Ranks for: Influenza Vaccine | 35 months | children 6 | dose tiv | safety immunogenicity |
BACKGROUND: Kawasaki disease is an acute self-limited vasculitis of childhood that is characterized by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, changes in the extremities, rash, and cervical lymphadenopathy. Coronary artery aneurysms or ectasia develop in approximately 15% to 25% of untreated children and may lead to ischemic heart disease or sudden death.
METHODS AND RESULTS: A multidisciplinary committee of experts was convened to revise the ...
| Also Ranks for: Kawasaki Disease | heart association | rheumatic fever | longterm management | health professionals |
BACKGROUND: The purpose of this statement is to update the recommendations by the American Heart Association (AHA) for the prevention of infective endocarditis, which were last published in 1997.
METHODS AND RESULTS: A writing group appointed by the AHA for their expertise in prevention and treatment of infective endocarditis (IE) with liaison members representing the American Dental Association, the Infectious Diseases Society of America and the American Academy of Pediatrics. The ...
| Also Ranks for: Heart Association | infective endocarditis | cardiovascular disease | dental procedures | prophylaxis prevention |
BACKGROUND: The purpose of this statement is to update the recommendations by the American Heart Association (AHA) for the prevention of infective endocarditis, which were last published in 1997.
METHODS: and
RESULTS: A writing group appointed by the AHA for their expertise in prevention and treatment of infective endocarditis (IE) with liaison members representing the American Dental Association, the Infectious Diseases Society of America and the American Academy of Pediatrics. The ...
| Also Ranks for: Infective Endocarditis | heart association | cardiovascular disease | dental procedures | antibiotic prophylaxis |
BACKGROUND: Kawasaki disease is an acute self-limited vasculitis of childhood that is characterized by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, changes in the extremities, rash, and cervical lymphadenopathy. Coronary artery aneurysms or ectasia develop in approximately 15% to 25% of untreated children and may lead to ischemic heart disease or sudden death.
METHODS AND RESULTS: A multidisciplinary committee of experts was convened to revise the ...
| Also Ranks for: Kawasaki Disease | term management | children fever | initial treatment | sudden death |
OBJECTIVES: To determine the effect of point-of-care testing (POCT) for influenza on the physician management of febrile children who are at risk for serious bacterial illness (SBI) on the basis of age and temperature and who are presenting to a pediatric emergency department (ED) during an influenza outbreak.
METHODS: Patients 2-3 months of age with temperature of > or = 38 degrees C and patients 3-24 months of age with temperature of > or = 39 degrees C who were presenting to a ...
| Also Ranks for: Influenza Testing | febrile children | age temperature | human length | positive poct |
BACKGROUND: Despite advances in medical, surgical, and critical care interventions, infective endocarditis remains a disease that is associated with considerable morbidity and mortality. The continuing evolution of antimicrobial resistance among common pathogens that cause infective endocarditis creates additional therapeutic issues for physicians to manage in this potentially life-threatening illness.
METHODS AND RESULTS: This work represents the third iteration of an infective ...
| Also Ranks for: Infective Endocarditis | heart association | treatment management | recommendations diagnosis | cardiovascular disease |
BACKGROUND: Trivalent inactivated influenza vaccine (TIV) is not licensed for use in infants <6 months old, the group with the highest influenza hospitalization rates among children.
METHODS: In this prospective, open-label study, 2 doses of TIV were administered to healthy infants aged 10-22 weeks. Adverse reactions were assessed, and hemagglutination inhibition (HAI) antibody titers were determined. Weekly telephone surveillance for influenza-like illness was conducted during the ...
| Also Ranks for: Influenza Vaccine | trivalent inactivated | infants vaccination | hemagglutination inhibition | antibody titers |
A Controlled Trial of Antimicrobial Prophylaxis for Lyme Disease after Deer-Tick Bites
[ PUBLICATION ]
BACKGROUND: Borrelia burgdorferi, which causes Lyme disease, is transmitted by deer ticks (lxodes dammini) in the northeastern and midwestern United States. Although deer-tick bites are common in areas in which the disease is endemic, there is uncertainty about how to manage the care of persons who are bitten.
METHODS: To assess the risk of infection with B. burgdorferi and the efficacy of prophylactic antimicrobial treatment after a deer-tick bite, we conducted a double-blind, ...
| Also Ranks for: Lyme Disease | tick bites | antimicrobial prophylaxis | risk infection | controlled trial |
CONTEXT: Few data exist about the long-term outcomes of patients with Lyme disease.
OBJECTIVE: To assess the long-term outcomes of patients with Lyme disease.
DESIGN: Two-part project including a community-based longitudinal cohort study and a matched cohort study.
SETTING AND PARTICIPANTS: Six hundred seventy-eight patients identified from a random sample of all reports of Connecticut residents with suspected Lyme disease submitted to the Connecticut Department of Public Health from ...
| Also Ranks for: Lyme Disease | longterm outcomes | daily activities | public health | cohort patients |
BACKGROUND: Administering 2 separate vaccines for seasonal and pandemic influenza was necessary in 2009. Therefore, we conducted a randomized trial of monovalent 2009 H1N1 influenza vaccine (2009 H1N1 vaccine) and seasonal trivalent inactivated influenza vaccine (TIV; split virion) given sequentially or concurrently in previously vaccinated children.
METHODS: Children randomized to 4 study groups and stratified by age received 1 dose of seasonal TIV and 2 doses of 2009 H1N1 vaccine in 1 ...
| Also Ranks for: 1 Dose | viral child child | immune responses | trivalent influenza | sequence vaccination |
Michael A Gerber: Influence Statistics
| Concept | World rank |
|---|---|
| 2 dilutions test | #1 |
| streptococcal carrier studies | #1 |
| antibiotic choices dosing | #1 |
| serial antibody tests | #1 |
| children cefadroxil | #1 |
| susceptibility gabhs | #1 |
| vitro susceptibility gabhs | #1 |
| streptococcal carrier state | #1 |
| guideline america | #1 |
| 73 patients penicillin | #1 |
| reports frequencies | #1 |
| cefadroxil effective | #1 |
| penicillin newer cephalosporins | #1 |
| initial throat cultures | #1 |
| pharyngitis antigens | #1 |
| gabhs erythromycin | #1 |
| idsa differential humans | #1 |
| streptococcal pharyngitis investigation | #1 |
| gabhs presence | #1 |
| gabhs pharyngitis penicillin | #1 |
| recommendations penicillinallergic patient | #1 |
| pharynx streptococcal infections | #1 |
| pharyngitis gabhs | #1 |
| effectiveness oral penicillin | #1 |
| findings current recommendation | #1 |
| current recommendation penicillin | #1 |
| receive penicillin | #1 |
| throat cultures gabhs | #1 |
| diagnose streptococcal | #1 |
| gabhs erythromycin resistance | #1 |
| cefadroxil child | #1 |
| longterm linezolid therapy | #1 |
| treatment gabhs | #1 |
| typical activities patients | #1 |
| penicillin potassium therapy | #1 |
| oia sensitive | #1 |
| erythromycin resistance gabhs | #1 |
| streptococcal pharyngitis cefadroxil | #1 |
| america guideline | #1 |
| negative oia | #1 |
| idsa adolescent | #1 |
| choice recommendations | #1 |
| acute pharyngitis diagnosis | #1 |
| case definition frequencies | #1 |
| state cefadroxil | #1 |
| oncedaily penicillin therapy | #1 |
| gabhs patients | #1 |
| nonpharyngeal findings penicillin | #1 |
Key People For Lyme Disease
Michael A Gerber:Expert Impact
Concepts for whichMichael A Gerberhas direct influence:Lyme disease, Infective endocarditis, Streptococcal pharyngitis, Kawasaki disease, Heart association, Rheumatic fever, Bacterial endocarditis, Gabhs pharyngitis.
Michael A Gerber:KOL impact
Concepts related to the work of other authors for whichfor which Michael A Gerber has influence:Kawasaki disease, Infective endocarditis, Antibiotic prophylaxis, Rheumatic fever, Coronary artery, Sore throat, Streptococcal pharyngitis.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |